Connect with us

Technology

Global Clinical Chemistry Analyzers Market Poised to Reach US$ 19.02 Billion by 2030 Amid Technological Advancements in Healthcare

Published

10 months ago

on

DUBLIN, Feb. 23, 2024 /PRNewswire/ — The “Clinical Chemistry Analyzers Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis” report has been added to  ResearchAndMarkets.com’s offering.

The global clinical chemistry analyzers market is forecasted to witness significant growth, with projections indicating an ascent to US$ 19.02 Billion by 2030. This robust expansion reflects a compound annual growth rate (CAGR) of 4.35% during the analysis period of 2023-2030. Such an upward trajectory is fueled by the rising prevalence of chronic diseases, surging health awareness, and the unparalleled advancements in healthcare technology that enhance the effectiveness of diagnostic tools and broaden the capabilities of clinical chemistry analyzers.

In the Spotlight: The Crucial Role of Reagents in Advance Diagnostics

The clinical chemistry analyzer segment of reagents stands as the foremost contributor to market dominance. These integral components of clinical chemistry analyzers are indispensable in the realm of medical diagnostics, enabling the precise detection and quantification of various biomarkers crucial for patient care. Their inimitability lies in their capacity to conduct accurate diagnostic assessments, propelling the reagents market to an unwavering position at the forefront of clinical research and diagnostics.

Basic Metabolic Panel (BMP) – Dominating the Diagnostic Landscape

An extensive analysis reveals that the Basic Metabolic Panel (BMP) dominates the clinical chemistry analyzer industry. BMP’s universal application in monitoring vital metabolic indicators enables healthcare practitioners to swiftly gauge and manage an array of metabolic dysfunctions and chronic illnesses. As healthcare systems pivot towards preventative healthcare, the value of BMPs in diagnostics is reinforced, thereby maintaining its significance within the medical chemistry analyzer arena.

Hospital Laboratories Leading in Clinical Chemistry Analyzer Usage

The clinical chemistry analyzers industry endows hospitals with a remarkable market share, cementing their stature as central to patient diagnosis, treatment planning, and continuous monitoring. Ensuring precise biomarker measurements, these analyzers are fundamental to hospital labs, aiding healthcare professionals in making critical care decisions and enhancing the precision of diagnostic and therapeutic methods.

United States: A Hub for Clinical Chemistry Analyzer Excellence

In the geographical dissection of the clinical chemistry analyzer market, the United States stands out as a nexus of innovation, leading the industry with technological sophistication and a robust presence. The U.S. healthcare sector’s commitment to developing superior healthcare solutions mirrors in the production of advanced clinical chemistry analyzers that satisfy the sophisticated demands of modern healthcare provision, cementing the U.S. as a powerhouse within the global healthcare apparatus.

Key Players

Thermo Fisher ScientificAbbott LaboratoriesSiemens HealthineersDanaher CorporationJohnson & JohnsonSysmex ADRHORIBA LtdHitachi

Product Type

AnalyzersReagentsOthers

Test Type

Basic Metabolic PanelLiver PanelRenal ProfileLipid ProfileThyroid Function PanelElectrolyte PanelSpecialty Chemical tests

End User

HospitalsDiagnostic LaboratoriesResearch Laboratories & InstitutesOthers

Region

North AmericaUnited StatesCanadaEuropeGermanyUnited KingdomFranceItalyNetherlandsSpainAsia PacificChinaSouth KoreaJapanIndiaIndonesiaMalaysiaAustraliaLatin AmericaArgentinaBrazilMexicoColombiaMiddle East & AfricaSaudi ArabiaUAEIsraelSouth AfricaRest of World

For more information about this report visit https://www.researchandmarkets.com/r/plhihq

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/global-clinical-chemistry-analyzers-market-poised-to-reach-us-19-02-billion-by-2030-amid-technological-advancements-in-healthcare-302069942.html

SOURCE Research and Markets

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Stora Enso Oyj: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (25 December 2024)

Published

33 minutes ago

on

December 27, 2024

By

STORA ENSO OYJ STOCK EXCHANGE RELEASE 27 December 2024 at 09:00 EET

HELSINKI, Dec. 27, 2024 /PRNewswire/ — Stora Enso Oyj received a notification pursuant to chapter 9, section 5 of the Securities Market Act from BlackRock, Inc on 27 December 2024.

On 25 December 2024, BlackRock’s holding in Stora Enso’s shares decreased below the 5 percent threshold.

% of shares and voting rights (total of 7.A)

% of shares and voting rights through financial instruments (total of 7.B)

Total of both in % (7.A + 7.B)

Resulting situation on the date on which threshold was crossed or reached

4.76% shares

Below 5% voting rights

0.27% shares

Below 5% voting rights

5.04% shares

Below 5% voting rights

Position of previous notification (if applicable)

Below 5% shares

Below 5% voting rights

Below 5% shares

Below 5% voting rights

Below 5% shares

Below 5% voting rights

 

A: Shares and voting rights

Class/type of shares

ISIN code (if possible)

Number of shares and voting rights

% of shares and voting rights

Direct

(SMA 9:5)

Indirect

(SMA 9:6 and 9:7)

Direct

(SMA 9:5)

Indirect

(SMA 9:6 and 9:7)

FI0009005961

37,609,170  shares

Below 5% voting rights

4.76% shares Below 5% voting rights

SUBTOTAL A

37,609,170 shares

Below 5% voting rights

4.76% shares

Below 5% voting rights

B: Financial Instruments according to SMA 9:6a

Type of financial instrument

Expiration date

Exercise/Conversion Period

Physical or cash settlement

Number of shares and voting rights

% of shares and voting rights

American Depositary Receipt (US86210M1062)

N/A

N/A

Physical

596,930 shares

Below 5% voting rights

0.07% shares

Below 5% voting rights

Securites lent

N7A

N/A

Physical

1,036,720 shares

Below 5% voting rights

0.13% shares

Below 5% voting rights

CFD

N/A

N/A

Cash

563,510 shares

Below 5% voting rights

0.07% shares

Below 5% voting rights

SUBTOTAL B

2,197,160 shares

Below 5% voting rights

0.27% shares

Below 5% voting rights

 

Stora Enso has two series of shares. Each A share and every ten R shares carry one vote. Stora Enso has 175,664,079 A shares and 612,955,908 R shares in issue. The Company does not hold its own shares. The total number of Stora Enso shares is 788,619,987 and the total number votes at least 236,959,669.

Investor enquiries:
Anna-Lena Åström
SVP Investor Relations
tel. +46 70 210 7691 

Stora Enso

Part of the global bioeconomy, Stora Enso is a leading provider of renewable products in packaging, biomaterials and wooden construction, and one of the largest private forest owners in the world. We create value with our low-carbon and recyclable fiber-based products, through which we support our customers in meeting the demand for renewable sustainable products. Stora Enso has approximately 20,000 employees and our sales in 2023 were EUR 9.4 billion. Stora Enso shares are listed on Nasdaq Helsinki Oy (STEAV, STERV) and Nasdaq Stockholm AB (STE A, STE R). In addition, the shares are traded in OTC Markets (OTCQX) in the USA as ADRs and ordinary shares (SEOAY, SEOFF, SEOJF). storaenso.com/investors

STORA ENSO OYJ

Investor enquiries:
Anna-Lena Åström
SVP Investor Relations
tel. +46 70 210 7691 

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/stora-enso-oyj/r/stora-enso-oyj–notification-of-change-in-holdings-according-to-chapter-9–section-10-of-the-finnish,c4086606

The following files are available for download:

https://mb.cision.com/Main/13589/4086606/3189711.pdf

STORA ENSO Class R_2024-12-25_Issuer

 

View original content:https://www.prnewswire.com/news-releases/stora-enso-oyj-notification-of-change-in-holdings-according-to-chapter-9-section-10-of-the-finnish-securities-markets-act-25-december-2024-302339535.html

SOURCE Stora Enso Oyj

Continue Reading

Technology

Truecaller continues strong growth, surpasses 400 million Android users

Published

33 minutes ago

on

December 27, 2024

By

STOCKHOLM, Dec. 27, 2024 /PRNewswire/ — Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, reached another important milestone on 24th of December, when the number of monthly active users (MAU) on the operating system Android surpassed 400 million. Truecaller continues to grow rapidly in many geographic markets and the total user base has grown with more than 57 million users during 2024 and has now surpassed 433 million users in total.

“Truecaller’s strong commitment to help businesses and individuals communicate better through both calls and messages, continues to grow. Our geographical footprint is growing each day, and the development in our targeted growth markets is strong. We’re thrilled at achieving this milestone and we look forward to serving the next 400 million Android users,” says Rishit Jhunjuhnwala, Chief Product Officer and incoming CEO of Truecaller.

The growth in India continues to be strong with a growth of approximately 37 million users in but the relative growth in other parts of the world is stronger with a growth of 20 million users during 2024.

Truecaller will continue to report the average number of monthly and daily users on a quarterly basis in connection with interim reports.

For more information, please contact:
Andreas Frid, Head of IR & Communication
+46 705 29 08 00
andreas.frid@truecaller.com

About Truecaller:

Truecaller (TRUE B) is the leading global platform for verifying contacts and blocking unwanted communication. We enable safe and relevant conversations between people and make it efficient for businesses to connect with consumers. Fraud and unwanted communication are endemic to digital economies. especially in emerging markets. We are on a mission to build trust in communication. Truecaller is an essential part of everyday communication for more than 433 million active users. Truecaller is listed on Nasdaq Stockholm since 8 October 2021. For more information. please visit corporate.truecaller.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/truecaller-ab/r/truecaller-continues-strong-growth–surpasses-400-million-android-users,c4086573

The following files are available for download:

 

View original content:https://www.prnewswire.com/news-releases/truecaller-continues-strong-growth-surpasses-400-million-android-users-302339536.html

SOURCE Truecaller AB

Continue Reading

Technology

Xinhua Silk Road: Conference on deepening financial openness and co-op in Northeast Asia held in NE. China’s Shenyang

Published

33 minutes ago

on

December 27, 2024

By

BEIJING, Dec. 27, 2024 /PRNewswire/ — The 2nd Northeast Asia Finance Conference and 2024 “Revitalizing Liaoning with Finance” Excellent Cases Release kicked off on Tuesday in Shenyang, capital of northeast China’s Liaoning Province, aiming to further deepen financial openness and cooperation in the Northeast Asian region and advance construction of a regional financial center.

The main forum held a series of activities, including an opening ceremony, two round-table dialogues on “finance + biomedical industry” and “finance + cultural industry”, a symposium for foreign financial institutions, a seminar on innovative development of financial clusters, a forum on development of technology and finance, a forum on industrial low-carbon transformation and financial innovation, as well as an enterprise project roadshow and industry-finance matchmaking event.

During the conference themed on “accelerating the construction of a regional financial center in Northeast Asia and creating a new highland for opening up”, excellent cases of revitalizing Liaoning through finance in 2024 were unveiled and the index for core areas of regional financial centers in northeast China was released.

The conference also held an unveiling ceremony for the upgrading of the Shenyang finance and trade development zone to a national-level development zone, and a launch ceremony of a platform for Shenyang industrial insights and decision analysis.

The conference was co-hosted by China Economic Information Service, Liaoning Branch of Xinhua News Agency, Shenhe District People’s Government, Shenyang local financial administration under guidance of Shenyang Municipal People’s Government and Liaoning local financial supervision and administration bureau.

Original link: https://en.imsilkroad.com/p/343777.html

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/xinhua-silk-road-conference-on-deepening-financial-openness-and-co-op-in-northeast-asia-held-in-ne-chinas-shenyang-302339540.html

SOURCE Xinhua Silk Road

Continue Reading

Trending